Moreover, downregulation of ZnT5 and ZnT6 mRNA is observed in the early stages of prostate cancer, and ZnT9 mRNA upregulation was observed in stage II of prostate cancer tumors10. The gene discussed is SLC30A9; the disease is prostate carcinoma.